Cristian Massacesi, Executive Vice President, Chief Medical Officer and Head of Development at Bristol Myers Squibb, shared on LinkedIn:
“I’m honored to share that starting January 1, 2027, I will lead a newly unified Research and Development organization at Bristol Myers Squibb.
Bringing research and development together end-to-end is something I genuinely believe in. When discovery and clinical development work as one, we make better decisions, move faster, and ultimately serve patients better.
I also want to recognize Robert Plenge. Robert is a remarkable scientist and leader of real depth and integrity. His contributions to BMS have left a lasting mark, and I am grateful for everything he has built.
To my colleagues across R and D, thank you. The work you do every day, the rigor you bring, and the patients you keep at the center of every decision. That is what makes BMS special.
We have a strong pipeline, great science, and a team that knows how to execute. I look forward to working together on what is ahead.
Read the full announcement here.”
Other articles about Cristian Massacesi on OncoDaily.